Amazon’s PillPack may be gearing up to serve the retailer’s employees before broader rollout, analyst says

Nov. 26, 2018

Amazon bought PillPack, an internet pharmacy start-up, earlier this year, leading to speculation that the e-retailer will soon start selling prescription drugs on its marketplace.

Before that happens, Amazon may be preparing to provide the service to its own employees.

PillPack recently applied for a string of new pharmacy licenses, primarily to ship drugs to customers from its Phoenix facility. The licenses in Washington, New Mexico, and Indiana were spotted this week by analysts at financial services firm Jefferies.

In a report to clients, the analysts said it appears that the licenses would allow PillPack to ship to those states from Phoenix. Previously, Jefferies noted that PillPack’s facility in Phoenix was only licensed to ship to Arizona and New Hampshire, where it’s headquartered. The company has been applying for more licenses in the past few months.

Customers in every U.S. state except Hawaii can already receive PillPack shipments, but they only get delivered from a handful of facilities. With more licenses in Phoenix, the company potentially gets faster access to people in Western states.

It’s particularly notable that PillPack is targeting Washington, because that would mean gaining access to employees at Amazon’s Seattle headquarters. Amazon has used a similar company-first strategy in other areas, including through its health joint venture with Berkshire Hathaway and J.P. Morgan Chase, where it’s first focusing on its own workers.

Amazon offers a very large testing ground. The company has hundreds of thousands of employees and has plans to add a combined 50,000 jobs at its two new headquarters offices, in New York City and the suburbs of Washington, D.C.

Clearly Amazon has bigger ambitions for PillPack after paying about $1 billion for the company earlier this year. Investors expect more as well. Shares of pharmacy owners Walgreens Boots Alliance, CVS Health and Rite Aid all plunged after the story of the deal broke.

Stephen Buck, an early employee at prescription drug marketplace GoodRx, said there’s no indication, based on the relatively tepid pace of expansion so far, that PillPack will be on par with pharmacy mail-order operations like Express Scripts or CVS anytime soon. Jefferies also noted that Express Scripts and other companies have far more facilities than PillPack, which until the Amazon acquisition was backed by venture money.

Instead, Buck said that PillPack, which specializes in packaging medicines for users with chronic ailments, is part of Amazon’s broader plan to build a direct-to-consumer pharmacy. Recent PillPack job listings reference Amazon’s mission to become the “earth’s most customer centric Pharmacy.”

CNBC has the full story

Sponsored Recommendations

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

TEST: Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

From Strategy to Action: The Power of Enterprise Value-Based Care

Ever wonder why your meticulously planned value-based care model hasn't moved beyond the concept stage? You're not alone! Transition from theory to practice with enterprise value...

State of the Market: Transforming Healthcare; Strategies for Building a Resilient and Adaptive Workforce

The U.S. healthcare system is facing critical challenges, including workforce shortages, high turnover, and regulatory pressures. This guide highlights the vital role of technology...